Business First: UB to be part of MS research effort

The University at Buffalo School of Medicine & Biomedical Sciences will share in a $12.1 million state research grant aimed at halting the progression of disability in multiple sclerosis patients.

Read about it: http://m.bizjournals.com/buffalo/

by Tracey Drury

Dr. Bianca Weinstock-Guttman, MD, co-principal investigator on the study, is Professor of Neurology, State University of New York at Buffalo, and Director of the Baird MS Center at The Jacobs Neurological Institute. She is also the Director of the Pediatric MS Center of the Jacobs Neurological Institute, one of six centers of excellence established by the National MS Society. In addition, she also serves as Executive Director of the New York State Multiple Sclerosis Consortium (NYSMSC).

Advertisements

Severe morning sickness patients get relief from anti-seizure drug

Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a UB faculty member who is conducting research on a drug that is showing success treating pregnant women with this condition.

Thomas Guttuso Jr., assistant professor of neurology in the School of Medicine and Biomedical Sciences, has been studying the drug gabapentin, an anti-seizure and anti-pain drug that he previously studied in cancer patients receiving chemotherapy.

Read about it:  http://www.buffalo.edu/ubreporter/

By Ellen Goldbaum